Japanese patent and new trademarks granted for Accel-HealĀ® EAE


We are delighted to announce that Accel-Heal's® EAE Japanese patent application has now been granted. Accel-Heal has also been granted trademark in Australia and New Zealand. These significant developments further expand Synapse's growing patent and trademark portfolios. 

John Gildersleeve, Synapse Electroceutical's Chief Executive Officer said "We are very pleased with these latest grants which provide Accel-Heal® EAE with due protection along with the already granted TGA approval for Australia and New Zealand. We also look forward to working towards regulatory approval in Japan in due course, to make Accel-Heal®EAE available to patients and clinicians". 


No Very

Captcha Image

Media Contact - Anita Uti, Marketing Manager.
e:anita@synapseec.com m:+44 (0)1959 569 433

Go Back